Predicting the reactivity of proteins from their sequence alone: Kazal family of protein inhibitors of serine proteinases.

An additivity-based sequence to reactivity algorithm for the interaction of members of the Kazal family of protein inhibitors with six selected serine proteinases is described. Ten consensus variable contact positions in the inhibitor were identified, and the 19 possible variants at each of these positions were expressed. The free energies of interaction of these variants and the wild type were measured. For an additive system, this data set allows for the calculation of all possible sequences, subject to some restrictions. The algorithm was extensively tested. It is exceptionally fast so that all possible sequences can be predicted. The strongest, the most specific possible, and the least specific inhibitors were designed, and an evolutionary problem was solved.

[1]  N. Green,et al.  Pancreatic trypsin inhibitor. II. Reaction with trypsin. , 1953, The Biochemical journal.

[2]  R. Feeney,et al.  The Trypsin and Chymotrypsin Inhibitors from Avian Egg Whites , 1960 .

[3]  A. Berger,et al.  On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.

[4]  M. Kimura,et al.  The neutral theory of molecular evolution. , 1983, Scientific American.

[5]  I. Kato,et al.  Protein inhibitors of proteinases. , 1980, Annual review of biochemistry.

[6]  M. Laskowski.  An algorithmic approach to sequence → reactivity of proteins , 1980 .

[7]  R J Read,et al.  Structure of the complex of Streptomyces griseus protease B and the third domain of the turkey ovomucoid inhibitor at 1.8-A resolution. , 1983, Biochemistry.

[8]  Protein-protein interactions: additivity of the free energies of association of amino acid residues. , 1985, Journal of theoretical biology.

[9]  W. Ardelt,et al.  Turkey ovomucoid third domain inhibits eight different serine proteinases of varied specificity on the same ...Leu18-Glu19 ... reactive site. , 1985, Biochemistry.

[10]  R. Huber,et al.  The crystal and molecular structure of the third domain of silver pheasant ovomucoid (OMSVP3). , 1985, European journal of biochemistry.

[11]  B. Merrifield,et al.  Solid phase synthesis , 1985, Science.

[12]  R. Huber,et al.  X‐ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. , 1986, The EMBO journal.

[13]  I. Kato,et al.  Positive darwinian selection in evolution of protein inhibitors of serine proteinases. , 1987, Cold Spring Harbor symposia on quantitative biology.

[14]  Randy J. Read,et al.  Crystal and molecular structures of the complex of α-chymotrypsin with its inhibitor Turkey ovomucoid third domain at 1.8 Å resolution , 1987 .

[15]  W. Ardelt,et al.  Ovomucoid third domains from 100 avian species: isolation, sequences, and hypervariability of enzyme-inhibitor contact residues. , 1987, Biochemistry.

[16]  I. Kato,et al.  Ovoinhibitor introns specify functional domains as in the related and linked ovomucoid gene. , 1987, The Journal of biological chemistry.

[17]  I. Kato,et al.  Chicken ovomucoid: determination of its amino acid sequence, determination of the trypsin reactive site, and preparation of all three of its domains. , 1987, Biochemistry.

[18]  T. Alber,et al.  Mutational effects on protein stability. , 1989, Annual review of biochemistry.

[19]  J. Wells,et al.  Additivity of mutational effects in proteins. , 1990, Biochemistry.

[20]  I. Apostol,et al.  Amino acid sequences of ovomucoid third domain from 25 additional species of birds , 1990, Journal of protein chemistry.

[21]  A. Fersht,et al.  Estimating the contribution of engineered surface electrostatic interactions to protein stability by using double-mutant cycles. , 1990, Biochemistry.

[22]  Replacement of P1 Leu18 by Glu18 in the reactive site of turkey ovomucoid third domain converts it into a strong inhibitor of Glu-specific Streptomyces griseus proteinase (GluSGP). , 1991, The Journal of biological chemistry.

[23]  W. Ardelt,et al.  Effect of single amino acid replacements on the thermodynamics of the reactive site peptide bond hydrolysis in ovomucoid third domain. , 1991, Journal of molecular biology.

[24]  A. Fersht,et al.  COSMIC analysis of the major α-helix of barnase during folding , 1991 .

[25]  D. Schomburg,et al.  Three-dimensional structure of the complexes between bovine chymotrypsinogen A and two recombinant variants of human pancreatic secretory trypsin inhibitor (Kazal-type). , 1991, Journal of molecular biology.

[26]  R. Huber,et al.  Natural protein proteinase inhibitors and their interaction with proteinases. , 1992, European journal of biochemistry.

[27]  D Schomburg,et al.  Three-dimensional structure of a recombinant variant of human pancreatic secretory trypsin inhibitor (Kazal type). , 1992, Journal of molecular biology.

[28]  S. Anderson,et al.  Water molecules participate in proteinase‐inhibitor interactions: Crystal structures of Leu18, Ala18, and Gly18 variants of turkey ovomucoid inhibitor third domain complexed with Streptomyces griseus proteinase B , 1995, Protein science : a publication of the Protein Society.

[29]  B. Matthews,et al.  Alanine scanning mutagenesis of the alpha-helix 115-123 of phage T4 lysozyme: effects on structure, stability and the binding of solvent. , 1995, Journal of molecular biology.

[30]  G Schreiber,et al.  Energetics of protein-protein interactions: analysis of the barnase-barstar interface by single mutations and double mutant cycles. , 1995, Journal of molecular biology.

[31]  D. Stachowiak,et al.  Antiproteolytic activity of goose pancreas: purification, inhibitory properties and amino-acid sequence of a Kazal type trypsin inhibitor. , 1996, Acta biochimica Polonica.

[32]  H. Sugita,et al.  The Protective Effects of Long-Acting Recombinant Human Pancreatic Secretory Trypsin Inhibitor (R44S-PSTI) in a Rat Model of Cerulein-Induced Pancreatitis , 1996, The Journal of international medical research.

[33]  S. Anderson,et al.  Binding of amino acid side-chains to S1 cavities of serine proteinases. , 1997, Journal of molecular biology.

[34]  M. Qasim,et al.  Interscaffolding additivity. Association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases. , 1997, Biochemistry.

[35]  K A Dill,et al.  Additivity Principles in Biochemistry* , 1997, The Journal of Biological Chemistry.

[36]  M. James,et al.  Computational analysis of the binding of P1 variants of domain 3 of turkey ovomucoid inhibitor to Streptomyces griseus protease B. , 1998, Journal of molecular biology.

[37]  R M Jackson,et al.  Comparison of protein–protein interactions in serine protease‐inhibitor and antibody‐antigen complexes: Implications for the protein docking problem , 2008, Protein science : a publication of the Protein Society.

[38]  S. Anderson,et al.  Deleterious effects of β‐branched residues in the S1 specificity pocket of Streptomyces griseus proteinase B (SGPB): Crystal structures of the turkey ovomucoid third domain variants Ile18I, Val18I, Thr18I, and Ser18I in complex with SGPB , 2008, Protein Science.

[39]  J. Kirsch,et al.  Role of the minor energetic determinants of chicken egg white lysozyme (HEWL) to the stability of the HEWL • antibody scFv‐10 complex , 2000, Proteins.